Tumor suppressor inactivation in the pathogenesis of adult T-cell leukemia

Journal of Oncology

Volumn 2015, Issue , 2015, Pages

  Nicot, Christophe ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; SECRETED FRIZZLED RELATED PROTEIN 1;

CD4+ T LYMPHOCYTE; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DNA REPAIR; EPIGENETICS; GENE INACTIVATION; GENE LOCUS; GENOMIC INSTABILITY; HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; REVIEW; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE;

EID: 84932630801     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2015/183590     Document Type: Review

References (145)

1. B. J. Poiesz, F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo, "Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma, " Proceedings of the National Academy of Sciences of the United States of America, vol. 77, no. 12, pp. 7415-7419, 1980
2. M. Yoshida, I. Miyoshi, and Y. Hinuma, "Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease, " Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 6, pp. 2031-2035, 1982
3. M. Yoshida, I. Miyoshi, and Y. Hinuma, "A retrovirus from human leukemia cell lines: its isolation, characterization, and implication in human adult T-cell leukemia (ATL), " Princess Takamatsu Symposia, vol. 12, pp. 285-294, 1982
4. A. Gessain and O. Cassar, "Epidemiological aspects and world distribution ofHTLV-1 infection, " Frontiers inMicrobiology, vol. 3, article 388, Article ID Article 388, 2012
5. M. Iwanaga, T. Watanabe, and K. Yamaguchi, "Adultt-cell leukemia: a review of epidemiological evidence, " Frontiers in Microbiology, vol. 3, article 322, 2012
6. K. Takatsuki, K. Yamaguchi, F. Kawano et al., "Clinical diversity in adult T-cell leukemia-lymphoma, " Cancer Research, vol. 45, pp. 4644s-4645s, 1985
7. K. Tsukasaki, O. Hermine, A. Bazarbachi et al., "Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting, " Journal of Clinical Oncology, vol. 27, no. 3, pp. 453-459, 2009
8. F. Wong-Staal, B. Hahn, V. Manzari et al., "A survey of human leukaemias for sequences of a human retrovirus, " Nature, vol. 302, no. 5909, pp. 626-628, 1983
9. M. Yoshida, M. Seiki, K. Yamaguchi, and K. Takatsuki, "Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease, " Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 8, pp. 2534-2537, 1984
10. A. Bazarbachi, F. Suarez, P. Fields, and O. Hermine, "How I treat adult T-cell leukemia/lymphoma, " Blood, vol. 118, no. 7, pp. 1736-1745, 2011
11. M. Shimoyama, "Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the lymphoma study group (1984-87), " British Journal of Haematology, vol. 79, no. 3, pp. 428-437, 1991
12. A. Bazarbachi, Y. Plumelle, J. C. Ramos et al., "Meta-Analysis on the use of zidovudine and interferon-Alfa in adult Tcell leukemia/lymphoma showing improved survival in the leukemic subtypes, " Journal of Clinical Oncology, vol. 28, no. 27, pp. 4177-4183, 2010
13. Y. Kfoury, R. Nasr, C. Journo, R. Mahieux, C. Pique, and A. Bazarbachi, "The multifaceted oncoprotein Tax. subcellular localization, posttranslationalmodifications, and NF-αBactivation, " Advances in Cancer Research, vol. 113, pp. 85-120, 2012
14. M. Bellon, H. H. Baydoun, Y. Yao, and C. Nicot, "HTLV-I taxdependent and -independent events associated with immortalization of human primary T lymphocytes, " Blood, vol. 115, no. 12, pp. 2441-2448, 2010
15. N. A. Gillet, N. Malani, A. Melamed et al., "The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones, " Blood, vol. 117, no. 11, pp. 3113-3122, 2011
16. C. Miller, T. Mohandas, D. Wolf, M. Prokocimer, V. Rotter, and H. P. Koeffler, "Human p53 gene localized to short arm of chromosome 17, " Nature, vol. 319, no. 6056, pp. 783-784, 1986
17. O.W.McBride, D. Merry, and D. Givol, "The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13), " Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 1, pp. 130-134, 1986
18. S. J. Baker, E. R. Fearon, J. M. Nigro et al., "Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas, " Science, vol. 244, no. 4901, pp. 217-221, 1989
19. J. M. Nigro, S. J. Baker, A. C. Preisinger et al., "Mutations in the p53 gene occur in diverse human tumour types, " Nature, vol. 342, no. 6250, pp. 705-708, 1989
20. G. Gaidano, P. Ballerini, J. Z. Gong et al., "p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia, " Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 12, pp. 5413-5417, 1991
21. A. Sakashita, T.Hattori, C.W.Miller et al., "Mutations of the p53 gene in adult T-cell leukemia, " Blood, vol. 79, no. 2, pp. 477-480, 1992
22. E. Cesarman, A. Chadburn, G. Inghirami, G. Gaidano, and D. M. Knowles, "Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations, " Blood, vol. 80, no. 12, pp. 3205-3216, 1992
23. H. Nagai, T. Kinoshita, J. Imamura et al., "Genetic alteration of p53 in some patients with adult T-cell leukemia, " Japanese Journal of Cancer Research, vol. 82, no. 12, pp. 1421-1427, 1991
24. M. Tawara, S. J.Hogerzeil, Y. Yamada et al., "Impact of p53 aberration on the progression of Adult T-cell leukemia/lymphoma, " Cancer Letters, vol. 234, no. 2, pp. 249-255, 2006
25. K. Yamato, T. Oka, M. Hiroi et al., "Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLVI-infected cells, " Japanese Journal of Cancer Research, vol. 84, no. 1, pp. 4-8, 1993
26. R. L.Reid, P. F. Lindholm, A.Mireskandari, J. Dittmer, and J.N. Brady, "Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I, " Oncogene, vol. 8, no. 11, pp. 3029-3036, 1993
27. S. Takemoto, R. Trovato, A. Cereseto et al., "p53 Stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(APF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells, " Blood, vol. 95, no. 12, pp. 3939-3944, 2000
28. T. Akagi, H. Ono, N. Tsuchida, and K. Shimotohno, "Aberrant expression and function of p53 in T cells immortalized by HTLV-I Tax1, " FEBS Letters, vol. 406, no. 3, pp. 263-266, 1997
29. C. A. Pise-Masison, K.-S. Choi, M. Radonovich, J. Dittmer, S.-J. Kim, and J.N. Brady, "Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein, " Journal of Virology, vol. 72, no. 2, pp. 1165-1170, 1998
30. C. A. Pise-Masison, R. Mahieux, H. Jiang et al., "Inactivation of p53 by human T-cell lymphotropic virus type 1 tax requires activation of the NF-αB pathway and is dependent on p53 phosphorylation, " Molecular and Cellular Biology, vol. 20, no. 10, pp. 3377-3386, 2000
31. J. C. Mulloy, T. Kislyakova, A. Cereseto et al., "Human T-cell lymphotropic/leukemia virus type 1 tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain, " Journal of Virology, vol. 72, no. 11, pp. 8852-8860, 1998
32. C. A. Pise-Masison, R. Mahieux, M. Radonovich, H. Jiang, and J. N. Brady, "Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell typedependent, " The Journal of Biological Chemistry, vol. 276, no. 1, pp. 200-205, 2001
33. N. L. Ko, J. M. Taylor, M. Bellon et al., "PA28 is a novel corepressor of HTLV-1 replication and controls viral latency, " Blood, vol. 121, no. 5, pp. 791-800, 2013
34. Y. Satou, J. I. Yasunaga, M. Yoshida, andM.Matsuoka, "HTLV-I basic leucine zipper factor genemRNAsupports proliferation of adult T cell leukemia cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 3, pp. 720-725, 2006
35. X. Agirre, F. J. Novo, M. J. Calasanz et al., "TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia, "Molecular Carcinogenesis, vol. 38, no. 4, pp. 201-208, 2003
36. D.-T. Wang, Z.-L. Ma, Y.-L. Li et al., "miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis, " Oncology Reports, vol. 30, no. 1, pp. 492-498, 2013
37. M. Bellon, Y. Lepelletier, O. Hermine, and C. Nicot, "Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia, " Blood, vol. 113, no. 20, pp. 4914-4917, 2009
38. S.-J. Jeong, M.Radonovich, J. N. Brady, andC.A.Pise-Masison, "HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity, " Blood, vol. 104, no. 5, pp. 1490-1497, 2004
39. M. Yamagishi, K. Nakano, A. Miyake et al., "Polycombmediated loss of miR-31 activates nik-dependent NF-αB pathway in adult T cell leukemia and other cancers, " Cancer Cell, vol. 21, no. 1, pp. 121-135, 2012
40. K.-J. Jung, A. Dasgupta, K. Huang et al., "Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells, " Journal of Virology, vol. 82, no. 17, pp. 8537-8547, 2008
41. A. Datta, M. Bellon, U. Sinha-Datta et al., "Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence, " Blood, vol. 108, no. 3, pp. 1021-1029, 2006
42. S. Ichimiya, Y.Nimura, H. Kageyama et al., "p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent, " Oncogene, vol. 18, no. 4, pp. 1061-1066, 1999
43. M. Kaghad, H. Bonnet, A. Yang et al., "Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers, " Cell, vol. 90, no. 4, pp. 809-819, 1997
44. S. Kawano, C. W. Miller, A. Gombart et al., "Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation, " Blood, vol. 94, no. 3, pp. 1113-1120, 1999
45. H. Sato, T. Oka, Y. Shinnou et al., "Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma, " The American Journal of Pathology, vol. 176, no. 1, pp. 402-415, 2010
46. I. Lemasson and J. K. Nyborg, "Human T-cell leukemia virus type I tax repression of p73 is mediated through competition for the C/H1 domain of CBP, "The Journal of Biological Chemistry, vol. 276, no. 19, pp. 15720-15727, 2001
47. A. Kaida, Y. Ariumi, Y. Ueda et al., "Functional impairment of p73 and p51, the p53-related proteins, by the human T-cell leukemia virus type 1 Tax oncoprotein, " Oncogene, vol. 19, no. 6, pp. 827-830, 2000
48. R. T. Williams and C. J. Sherr, "The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias, " Cold Spring Harbor Symposia on Quantitative Biology, vol. 73, pp. 461-467, 2008
49. C. Caldas, S. A. Hahn, L. T. da Costa et al., "Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma, " Nature Genetics, vol. 8, no. 1, pp. 27-32, 1994
50. D. Bartsch, D. W. Shevlin, W. S. Tung, O. Kisker, S. A. Wells Jr., and P. J. Goodfellow, "Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas, " Genes Chromosomes and Cancer, vol. 14, no. 3, pp. 189-195, 1995
51. L. Liu, N. J. Lassam, J. M. Slingerland et al., "Germline p16INK4A mutation and protein dysfunction in a family with inheritedmelanoma, " Oncogene, vol. 11, no. 2, pp. 404-412, 1995
52. R. Trovato, A. Cereseto, S. Takemoto et al., "Deletion of the p16 4 gene in ex vivo acute adult T cell lymphoma/leukemia cells and methylation of the p16 4 promoter in HTLV type I-infected T cell lines, " AIDS Research and Human Retroviruses, vol. 16, no. 8, pp. 709-713, 2000
53. T. Uchida, T. Kinoshita, T. Murate, H. Saito, and T. Hotta, "CDKN2 (MTS1/p16 4) gene alterations in adult T-cell leukemia/lymphoma, " Leukemia & Lymphoma, vol. 29, no. 1-2, pp. 27-35, 1998
54. Y.Hatta, T.Hirama, C.W.Miller, Y. Yamada, M. Tomonaga, and H. P. Koeffler, "Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia, " Blood, vol. 85, no. 10, pp. 2699-2704, 1995
55. K. Uenogawa, Y. Hatta, N. Arima et al., "Azacitidine induces demethylation of p16INK4a and inhibits growth in adult Tcell leukemia/lymphoma, " International Journal of Molecular Medicine, vol. 28, no. 5, pp. 835-839, 2011
56. M. S. Pombo-de-Oliveira, J. A. Dobbin, P. Loureiro et al., "Genetic mutation and early onset of T-cell leukemia in pediatric patients infected at birth with HTLV-I, " Leukemia Research, vol. 26, no. 2, pp. 155-161, 2002
57. M. J. Bueno and M.Malumbres, "MicroRNAs and the cell cycle, " Biochimica et Biophysica Acta, vol. 1812, no. 5, pp. 592-601, 2011
58. M. J. Bueno, I. P. De Castro, and M.Malumbres, "Control of cell proliferation pathways by microRNAs, " Cell Cycle, vol. 7, no. 20, pp. 3143-3148, 2008
59. M. Yamagishi, K. Nakano, A. Miyake et al., "Polycombmediated loss of miR-31 activates nik-dependent NF-αB pathway in adult T cell leukemia and other cancers, " Cancer Cell, vol. 21, no. 1, pp. 121-135, 2012
60. T. Suzuki, T. Narita, M. Uchida-Toita, and M. Yoshida, "Downregulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms, " Virology, vol. 259, no. 2, pp. 384-391, 1999
61. T. Suzuki, S. Kitao, H. Matsushime, and M. Yoshida, "HTLV-1 tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4, " The EMBO Journal, vol. 15, no. 7, pp. 1607-1614, 1996
62. D. Bertwistle, M. Sugimoto, and C. J. Sherr, "Physical and functional interactions of theArf tumor suppressor proteinwith nucleophosmin/B23, " Molecular and Cellular Biology, vol. 24, no. 3, pp. 985-996, 2004
63. H. Rizos, A. P. Darmanian, E. A. Holland, G. J. Mann, and R. F. Kefford, "Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF, " The Journal of Biological Chemistry, vol. 276, no. 44, pp. 41424-41434, 2001
64. N. Burri, P. Shaw, H. Bouzourene et al., "Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer, " Laboratory Investigation, vol. 81, no. 2, pp. 217-229, 2001
65. D. K. Bartsch, M. Sina-Frey, S. Lang et al., "CDKN2A germline mutations in familial pancreatic cancer, " Annals of Surgery, vol. 236, no. 6, pp. 730-737, 2002
66. S. W. Blain, E. Montalvo, and J. Massagué, "Differential interaction of the cyclin-dependent kinase (CDK) inhibitor p27 1 with cyclin A-Cdk2 and cyclin D2-Cdk4, " The Journal of Biological Chemistry, vol. 272, no. 41, pp. 25863-25872, 1997
67. J. Labaer, M. D. Garrett, L. F. Stevenson et al., "New functional activities for the p21 family of CDK inhibitors, " Genes and Development, vol. 11, no. 7, pp. 847-862, 1997
68. Y.Hashimoto, K.Kohri, Y.Kaneko et al., "Critical role for the 310 helix region of p57 2 in cyclin-dependent kinase 2 inhibition and growth suppression, "The Journal of Biological Chemistry, vol. 273, no. 26, pp. 16544-16550, 1998
69. W. S. El-Deiry, T. Tokino, V. E. Velculescu et al., "WAF1, a potential mediator of p53 tumor suppression, " Cell, vol. 75, no. 4, pp. 817-825, 1993
70. A. L. Gartel and S.K. Radhakrishnan, "Lost in transcription: p21 repression, mechanisms, and consequences, " Cancer Research, vol. 65, no. 10, pp. 3980-3985, 2005
71. C. De la Fuente, F. Santiago, L. Deng et al., "Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2, " Journal of Virology, vol. 74, no. 16, pp. 7270-7283, 2000
72. M. Watanabe, S. Nakahata, M. Hamasaki et al., "Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines, " Journal of Virology, vol. 84, no. 14, pp. 6966-6977, 2010
73. Y.-K. Kim, J. Yu, T. S. Han et al., "Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer, " Nucleic Acids Research, vol. 37, no. 5, pp. 1672-1681, 2009
74. G. C. Sampey, R. Van Duyne, R. Currer, R. Das, A. Narayanan, and F. Kashanchi, "Complex role of microRNAs in HTLV-1 infections, " Frontiers in Genetics, vol. 3, article 295, 2012
75. A. Cereseto, R. W. Parks, E. Rivadeneira, and G. Franchini, "Limiting amounts of p27 1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T cells, " Oncogene, vol. 18, no. 15, pp. 2441-2450, 1999
76. R.Morosetti, N. Kawamata, A. F. Gombart et al., "Alterations of the p27KIP1 Gene in Non-Hodgkin's Lymphomas and Adult TCell Leukemia/Lymphoma, " Blood, vol. 86, no. 5, pp. 1924-1930, 1995
77. W. Roeb, A. Boyer, W. K. Cavenee, and K. C. Arden, "PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 46, pp. 18085-18090, 2007
78. S. Matsuoka, M. C. Edwards, C. Bai et al., "P57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene, " Genes and Development, vol. 9, no. 6, pp. 650-662, 1995
79. I. Hatada, A. Nabetani, H. Morisaki et al., "New p57 2 mutations in Beckwith-Wiedemann syndrome, " Human Genetics, vol. 100, no. 5-6, pp. 681-683, 1997
80. I. S. Pateras, K. Apostolopoulou, K. Niforou, A. Kotsinas, and V. G. Gorgoulis, "p57KIP2: 'kip'ing the cell under control, " Molecular Cancer Research, vol. 7, no. 12, pp. 1902-1919, 2009
81. X. Yang, R. K. M. Karuturi, F. Sun et al., "CDKN1C (p57 2) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells, " PLoS ONE, vol. 4, Article ID e5011, 2009
82. L. Shen, M. Toyota, Y. Kondo et al., "AberrantDNAmethylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia, " Blood, vol. 101, no. 10, pp. 4131-4136, 2003
83. F. Fornari, L. Gramantieri, M. Ferracin et al., "MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma, " Oncogene, vol. 27, no. 43, pp. 5651-5661, 2008
84. R. Medina, S. K. Zaidi, C.-G. Liu et al., "MicroRNAs 221 and 222 bypass quiescence and compromise cell survival, " Cancer Research, vol. 68, no. 8, pp. 2773-2780, 2008
85. S. Sengupta, J. Nie, R. J. Wagner, C. Yang, R. Stewart, and J. A. Thomson, "MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells, " Stem Cells, vol. 27, no. 7, pp. 1524-1528, 2009
86. D. G. Johnson and R. Schneider-Broussard, "Role of E2F in cell cycle control and cancer, " Frontiers in Bioscience, vol. 3, pp. d447-d448, 1998
87. S. A. Henley and F. A. Dick, "The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle, " Cell Division, vol. 7, article 10, 2012
88. P. Indovina, E. Marcelli, N. Casini, V. Rizzo, and A. Giordano, "Emerging roles of RB family: new defensemechanisms against tumor progression, " Journal of Cellular Physiology, vol. 228, no. 3, pp. 525-535, 2013
89. Y. Hatta, Y. Yamada, M. Tomonaga, and H. P. Koeffler, "Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL), " Leukemia, vol. 11, no. 7, pp. 984-989, 1997
90. S. Takeuchi, N. Takeuchi, K. Tsukasaki et al., "Mutations in the retinoblastoma-related gene RB2/p130 in adult T-cell leukaemia/lymphoma, " Leukemia and Lymphoma, vol. 44, no. 4, pp. 699-701, 2003
91. A.Hangaishi, S. Ogawa, N. Imamura et al., "Inactivation ofmultiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies, " Blood, vol. 87, no. 12, pp. 4949-4958, 1996
92. K. Nakayama, Y. Yamada, T. Koji, T. Hayashi, M. Tomonaga, and S. Kamihira, "Expression and phosphorylation status of retinoblastoma protein in adult T-cell leukemia/lymphoma, " Leukemia Research, vol. 24, no. 4, pp. 299-305, 2000
93. D. Jiang and R. C. T. Aguiar, "MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-α1/SMAD5 signaling module, " Blood, vol. 123, no. 1, pp. 86-93, 2014
94. K. Kehn, C. De la Fuente, K. Strouss et al., "The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation, " Oncogene, vol. 24, no. 4, pp. 525-540, 2005
95. P. A. Steck, M. A. Pershouse, S. A. Jasser et al., "Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers, " Nature Genetics, vol. 15, no. 4, pp. 356-362, 1997
96. Y. Yin andW. H. Shen, "PTEN: a new guardian of the genome, " Oncogene, vol. 27, no. 41, pp. 5443-5453, 2008
97. E. C. Chu and A. S. Tarnawski, "PTEN regulatory functions in tumor suppression and cell biology, " Medical Science Monitor, vol. 10, no. 10, pp. RA235-RA241, 2004
98. M. C. Hollander, G. M. Blumenthal, and P. A. Dennis, "PTEN loss in the continuum of common cancers, rare syndromes and mouse models, " Nature Reviews Cancer, vol. 11, no. 4, pp. 289-301, 2011
99. J. Pancewicza, J. M. Taylora, A. Dattaa et al., "Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-Associated adult T-cell leukemia, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 38, pp. 16619-16624, 2010
100. J. E. Damen, L. Liu, P. Rosten et al., "The 145-kDa protein induced to associate with She by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3, 4, 5-trisphosphate 5-phosphatase, " Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 4, pp. 1689-1693, 1996
101. G. Krystal, J. E. Damen, C. D. Helgason et al., "SHIPs ahoy, " International Journal of Biochemistry and Cell Biology, vol. 31, no. 10, pp. 1007-1010, 1999
102. K. Nakase, J. Cheng, Q. Zhu, andW. A. Marasco, "Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells, " Journal of Leukocyte Biology, vol. 85, no. 1, pp. 165-174, 2009
103. Q. Zhang, P. N. Raghunath, E. Vonderheid, N.Odum, andM. A. Wasik, "Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter, "American Journal of Pathology, vol. 157, no. 4, pp. 1137-1146, 2000
104. J. Cheng, D. Zhang, C. Zhou, and W. A. Marasco, "Downregulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T cells, " Leukemia Research, vol. 28, no. 1, pp. 71-82, 2004
105. T.-S.Migone, N. A. Cacalano, N. Taylor, T. Yi, T. A.Waldmann, and J. A. Johnston, "Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type Itransformed T cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 7, pp. 3845-3850, 1998
106. M. Garofalo, G. Di Leva, G. Romano et al., "miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation, " Cancer Cell, vol. 16, no. 6, pp. 498-509, 2009
107. Y.-N. Bai, Z.-Y. Yu, L.-X. Luo, J. Yi, Q.-J. Xia, and Y. Zeng, "MicroRNA-21 accelerates hepatocyte proliferation in vitro via PI3K/Akt signaling by targeting PTEN, " Biochemical and Biophysical Research Communications, vol. 443, no. 3, pp. 802-807, 2014
108. R. M. O'Connell, A. A. Chaudhuri, D. S. Rao, andD. Baltimore, "Inositol phosphatase SHIP1 is a primary target of miR-155, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 17, pp. 7113-7118, 2009
109. G. M. Caldwell, C. Jones, K. Gensberg et al., "The Wnt antagonist sFRP1 in colorectal tumorigenesis, " Cancer Research, vol. 64, no. 3, pp. 883-888, 2004
110. R. Stoehr, C.Wissmann, H. Suzuki et al., "Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer, " Laboratory Investigation, vol. 84, no. 4, pp. 465-478, 2004
111. M. L. Gumz, H. Zou, P. A. Kreinest et al., "Secreted frizzledrelated protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma, " Clinical Cancer Research, vol. 13, no. 16, pp. 4740-4749, 2007
112. T. Fukui, M. Kondo, G. Ito et al., "Transcriptional silencing of secreted frizzled related protein 1 (SFRP1) by promoter hypermethylation in non-small-cell lung cancer, "Oncogene, vol. 24, no. 41, pp. 6323-6327, 2005
113. E. Dahl, J. Veeck, H. An et al., "Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer, " Verhandlungen Der Deutschen Gesellschaft für Pathologie, vol. 89, pp. 169-177, 2005
114. U. Sinha-Datta, I. Horikawa, E. Michishita et al., "Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells, " Blood, vol. 104, no. 8, pp. 2523-2531, 2004
115. N. Uchida, T. Otsuka, F. Arima et al., "Correlation of telomerase activity with development and progression of adult T-cell leukemia, " Leukemia Research, vol. 23, no. 3, pp. 311-316, 1999
116. Y. Kubuki, M. Suzuki, H. Sasaki et al., "Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia, " Leukemia and Lymphoma, vol. 46, no. 3, pp. 393-399, 2005
117. C.Nicot, R.Mahieux, S. Takemoto, and G. Franchini, "Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples, " Blood, vol. 96, no. 1, pp. 275-281, 2000
118. Y. B. Choi, E. W. Harhaj, and S. R. Ross, "HTLV-1 tax stabilizes MCL-1 via TRAF6-dependent K63-linked polyubiquitination to promote cell survival and transformation, " PLoS Pathogens, vol. 10, no. 10, 2014
119. A. Kawakami, T. Nakashima, H. Sakai et al., "Inhibition of caspase cascade by HTLV-I tax through induction of NF-αB nuclear translocation, " Blood, vol. 94, no. 11, pp. 3847-3854, 1999
120. H.Macaire, A. Riquet, V.Moncollin et al., "Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells, "The Journal of Biological Chemistry, vol. 287, no. 25, pp. 21357-21370, 2012
121. A. Formosa, A.M. Lena, E. K.Markert et al., "DNAmethylation silences miR-132 in prostate cancer, " Oncogene, vol. 32, no. 1, pp. 127-134, 2013
122. M. L. Ufkin, S. Peterson, X. Yang, H. Driscoll, C. Duarte, and P. Sathyanarayana, "miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia, " Leukemia Research, vol. 38, no. 3, pp. 402-410, 2014
123. T. Itoyama, R. S. K. Chaganti, Y. Yamada et al., "Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki, " Blood, vol. 97, no. 11, pp. 3612-3620, 2001
124. N. Kamada, M. Sakurai, K. Miyamoto et al., "Chromosome abnormalities in adult T-cell leukemia/lymphoma: a Karyotype Review Committee report, " Cancer Research, vol. 52, no. 6, pp. 1481-1493, 1992
125. T. Dayaram, F. J. Lemoine, L. A. Donehower, and S. J.Marriott, "Activation of WIP1 phosphatase by HTLV-1 Tax mitigates the cellular response to DNA damage, " PLoS ONE, vol. 8, no. 2, Article ID e55989, 2013
126. C. Chandhasin, R. I. Ducu, E. Berkovich, M. B. Kastan, and S. J. Marriott, "Human T-cell leukemia virus type 1 tax attenuates the ATM-mediated cellular DNA damage response, " Journal of Virology, vol. 82, no. 14, pp. 6952-6961, 2008
127. H. U. Park, S.-J. Jeong, J.-H. Jeong, J. H. Chung, and J. N. Brady, "Human T-cell leukemia virus type 1 Tax attenuates -irradiation-induced apoptosis through physical interaction with Chk2, " Oncogene, vol. 25, no. 3, pp. 438-447, 2006
128. B. Liu, M.-H. Liang, Y.-L. Kuo et al., "Human T-lymphotropic virus type 1 oncoprotein tax promotes unscheduled degradation of Pds1p/securin and Clb2p/cyclin B1 and causes chromosomal instability, " Molecular and Cellular Biology, vol. 23, no. 15, pp. 5269-5281, 2003
129. T.Nitta, M. Kanai, E. Sugihara et al., "Centrosome amplification in adult T-cell leukemia and human T-cell leukemia virus type 1 Tax-induced human T cells, " Cancer Science, vol. 97, no. 9, pp. 836-841, 2006
130. H. Chaib-Mezrag, D. Lemaçon, H. Fontaine et al., "Tax impairs DNA replication forks and increases DNA breaks in specific oncogenic genome regions, " Molecular Cancer, vol. 13, article 205, 2014
131. H. H. Baydoun, X. T. Bai, S. Shelton, and C. Nicot, "HTLV-I tax increases genetic instability by inducingDNA double strand breaks during DNA replication and switching repair to NHEJ, " PLoS ONE, vol. 7, no. 8, Article ID e42226, 2012
132. J. German, "Bloom's syndrome. I. Genetical and clinical observations in the first twenty-seven patients., " The American Journal of Human Genetics, vol. 21, no. 2, pp. 196-227, 1969
133. Y.Hatta, Y. Yamada, M. Tomonaga, I.Miyoshi, J.W. Said, and H. P. Koeffler, "Microsatellite instability in adult T-cell leukaemia, " British Journal of Haematology, vol. 101, no. 2, pp. 341-344, 1998
134. Y. Hayami, H. Komatsu, S. Iida et al., "Microsatellite instability as a potential marker for poor prognosis in adult T cell leukemia/lymphoma, " Leukemia and Lymphoma, vol. 32, no. 3-4, pp. 345-349, 1999
135. Y.Hatta, Wada M., S. Takeuchi et al., "Mutational analysis of the hMSH2 gene in a wide variety of tumors, " International Journal of Oncology, vol. 11, no. 3, pp. 465-469, 1997
136. H.Morimoto, J. Tsukada, Y. Kominato, andY. Tanaka, "Reduced expression of human mismatch repair genes in adult T-cell leukemia, " The American Journal of Hematology, vol. 78, no. 2, pp. 100-107, 2005
137. F. J. Lemoine, S.-Y. Kao, and S. J. Marriott, "Suppression of DNA repair by HTLV type 1 Tax correlates with Tax transactivation of proliferating cell nuclear antigen gene expression, " AIDS Research andHuman Retroviruses, vol. 16, no. 16, pp. 1623-1627, 2000
138. S.-Y. Kao and S. J. Marriott, "Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein, " Journal of Virology, vol. 73, no. 5, pp. 4299-4304, 1999
139. S. M. Philpott and G. C. Buehring, "Defective DNA repair in cells with human T-cell leukemia/bovine leukemia viruses: role of tax gene, " Journal of theNational Cancer Institute, vol. 91, no. 11, pp. 933-942, 1999
140. M. Boxus, J.-C.Twizere, S.Legros, R. Kettmann, andL.Willems, "Interaction of HTLV-1 Tax with minichromosome maintenance proteins accelerates the replication timing program, " Blood, vol. 119, no. 1, pp. 151-160, 2012
141. H. Sasaki, I. Nishikata, T. Shiraga et al., "Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia, " Blood, vol. 105, no. 3, pp. 1204-1213, 2005
142. M. Z. Dewan, N. Takamatsu, T. Hidaka et al., "Critical role for TSLC1 expression in the growth and organ infiltration of adult T-cell leukemia cells in vivo, " Journal of Virology, vol. 82, no. 23, pp. 11958-11963, 2008
143. N. Mori, H. Sato, T. Hayashibara et al., "HumanT-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness, " Blood, vol. 99, no. 4, pp. 1341-1349, 2002
144. K. Nabeshima, J. Suzumiya, M. Nagano et al., "Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas, " The Journal of Pathology, vol. 202, no. 3, pp. 341-351, 2004
145. M. Masuda, T. Maruyama, T. Ohta et al., "CADM1 interacts with Tiam1 and promotes invasive phenotype of human Tcell leukemia virus type I-transformed cells and adult T-cell leukemia cells, "The Journal of Biological Chemistry, vol. 285, no. 20, pp. 15511-15522, 2010